clinical trial · NCT04949828
Effect of CREON on Exocrine Pancreatic Insufficiency (EPI) Symptoms
AbbVie·—·completed·n = 63
Chronic PancreatitisCREON
brief summary
Exocrine Pancreatic Insufficiency (EPI) is a condition where pancreatic enzyme quantity or activity is reduced below threshold needed for normal digestion. Symptoms include bloating, flatulence, diarrhea and steatorrhea. This is an observational study assessing for effect of CREON on symptoms of EPI in participants with EPI due to chronic pancreatitis.
started
Sep 16, 2021
primary completion
Feb 29, 2024
completion
Feb 29, 2024
last updated
Mar 28, 2024
official title
Observational Study Assessing for Effect of CREON on Symptoms of Exocrine Pancreatic Insufficiency (EPI) in Patients With EPI Due to Chronic Pancreatitis (CP)
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol